Genome International Biomedical Co. Ltd filed its Annual on Mar 27, 2015 for the period ending Dec 31, 2014. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.9 TWD | +1.06% | -3.82% | -30.52% |
1st Jan change | Capi. | |
---|---|---|
-30.52% | 32.85M | |
+21.11% | 72.89B | |
-4.38% | 23.48B | |
+4.16% | 8.51B | |
+9.26% | 8.42B | |
-24.53% | 7.56B | |
+13.31% | 5.22B | |
0.00% | 4.2B | |
+6.13% | 3.91B | |
-1.31% | 3.91B |
- Stock Market
- Equities
- 6130 Stock
- News Shangya Technology Co., Ltd.
- Genome International Biomedical Co. Ltd Auditor Raises 'Going Concern' Doubt